Procedures & recovery · patient guide

Rare-Disease MDT Review in China: Communicating With Your Home Medical Team

The exchange works best when you name one responsible person on each side, send a short index of records rather than an unlabelled archive, and put your home team's actual questions in writing. The China review team then states what it can assess from those records and what remains open. Nothing is confirmed until the receiving hospital accepts the case.

Go to the practical guidance ↓
Editorial illustration: Rare-Disease MDT Review in China: Communicating With Your Home Medical Team
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Who is actually exchanging information, and who owns each step

A rare-disease multidisciplinary review involves more than one specialty looking at the same file. That makes the handover between your home clinicians and the China side an administrative task with real consequences: if nobody owns it, records arrive in fragments and the questions you most want answered are never put to the right person.

Before anything is sent, decide who speaks for each side. At home, that is often the clinician who knows the case best, or a specialist nurse or clinic administrator acting on that clinician's instruction. On the China side, the review is arranged through a coordinator who organises documents and appointment requests, while the clinical assessment itself belongs to the hospital specialists. The coordinator does not decide suitability, diagnosis or treatment.

Write these names down. A short list is more useful than a long explanation:

Keep this list current. If your home clinician changes, or a new specialist joins the case, the exchange should be updated rather than left to drift.

  • Home-side contact: name, role, department, preferred contact method and language.
  • China-side contact: the person handling your enquiry, and the hospital department once a review is arranged.
  • Who authorises release of each document, and who receives the reply.
  • What each side is expected to do, and by when, in plain terms.

What to send first: a short index, not a complete archive

An initial enquiry does not need your whole medical history. It needs enough for the team to understand the diagnosis, the main question and what has already been tried, so they can identify what is missing and suggest the relevant next step. Sending an unlabelled pile of scans and discharge letters makes that harder, not easier.

Start with a one-page summary written by you or your home clinician. It should state the working diagnosis, when it was made, the main current concern, and the specific question you want the review to address. Then list the documents you hold, with dates and source, so the China side can request what it actually needs.

For a rare-disease review, the documents that matter are usually the ones that establish the diagnosis and the ones that show how the condition has changed over time. Which specific items are relevant depends on the case, so treat the following as examples to confirm with the receiving team rather than a fixed list:

Label every file with the patient's name, the document type and its date. If a document is in another language, say so, and ask whether a translation is needed before it is reviewed. Do not send passport numbers, payment details or a complete archive at first contact.

  • Clinic letters and discharge summaries that state the diagnosis and its basis.
  • Genetic or laboratory reports already performed, with the laboratory name and date.
  • Imaging reports, and the images themselves if the receiving team asks for them.
  • A list of current medicines and known reactions, prepared by your home clinician.
  • The written question your home team wants answered.

Putting your home team's real questions in writing

A records-based review can only answer questions that are actually asked. Vague requests such as "please advise" produce vague replies. Ask your home clinician to write two or three specific questions, in order of importance, and to state what decision each answer would change.

Useful questions are usually about the diagnostic pathway, whether the working diagnosis is supported by the records, what additional information would change the assessment, and whether any option discussed at home is available or appropriate to consider further. The China review team can state what it can and cannot assess from the documents; it cannot confirm eligibility for a trial, transplant or therapy from a file alone.

Ask your home clinician to note any constraints that matter to them: treatments already tried, treatments that are not appropriate, and any local limits on what can be offered. This prevents the review from proposing something your home team has already ruled out for a documented reason.

If your home team prefers to communicate directly with the China specialists, ask whether that is possible and in what form. Do not assume it is arranged; confirm it in writing before relying on it.

Agreeing the written scope before the review starts

Before a multidisciplinary review is arranged, the scope and fee are agreed first. That agreement should be in writing and should say which specialties are involved, what documents will be reviewed, what the output will be, and what is not included. A review involving two or three relevant specialties may be arranged for a complex or cross-specialty case.

Ask the provider what its written quote or plan includes, and what remains undecided. Do not assume a particular item is included or excluded. If the scope changes after you send more records, ask for the change to be confirmed in writing before the review proceeds.

Coordination fees and hospital medical fees are separate. Hospital consultations, tests, treatment, medicines and rooms are paid to the hospital or the relevant provider. Ask who is paid for what, and keep the answer with your records.

A preliminary reply is not a final assessment. It usually means the team has read the summary and identified what is missing. Treat it as a request for specific documents or clarification, not as confirmation that a review will proceed or that the hospital will accept the case.

Related treatment reference

How the reply comes back, and what it does not settle

Ask in advance how the review output will be delivered, in what language, and to whom. If your home clinician needs the reply in a specific format for their own records, say so before the review starts. Do not assume a particular format or delivery method; confirm it.

When the reply arrives, read it as an assessment based on the documents provided, not as a decision about your care. It may state that the records are insufficient for a conclusion, that a further document would help, or that the question falls outside the specialties involved. Each of those is a useful answer because it tells you what to do next.

The receiving hospital decides suitability and acceptance. A review does not establish trial enrolment, transplant access or therapy availability. If the reply mentions an option, ask your home clinician whether it is relevant to your situation and what would need to be confirmed before any travel is considered.

Keep the exchange in one place. A shared folder or a single email thread with dated documents is easier to hand over than messages scattered across apps. If a document is replaced by a newer version, say so clearly so the older one is not reviewed by mistake.

A practical next step for this exchange

Start with a short summary by the enquiry form, email or WhatsApp. State the working diagnosis, your main question and the documents you hold. You do not need to buy a proxy consultation to make an initial enquiry, and you do not need to send a complete medical archive at first contact.

If you would like help organising records, preparing the written questions or requesting a specialist appointment, ChinaSpecialistCare can assist with that coordination. The clinical assessment and any decision about suitability remain with the hospital specialists.

Then take one concrete action: ask your home clinician to write the two or three questions they most want answered, and send those with your document index. That single step turns a general enquiry into a review that can actually address your case.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. ChinaSpecialistCare: Rare-Disease MDT Review in China

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.